{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T15:07:44Z","timestamp":1649084864909},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,10,11]],"date-time":"2007-10-11T00:00:00Z","timestamp":1192060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1477-7819-5-114","type":"journal-article","created":{"date-parts":[[2007,10,11]],"date-time":"2007-10-11T02:13:17Z","timestamp":1192068797000},"source":"Crossref","is-referenced-by-count":0,"title":["Complications after oesophagectomy with possible contribution of neoadjuvant therapy including an EGFR-antibody to a fatal outcome"],"prefix":"10.1186","volume":"5","author":[{"given":"Michael","family":"Knauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Haid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karlheinz","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alois","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Offner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"T\u00fcrtscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Cerkl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Wenzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,11]]},"reference":[{"key":"366_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108.","journal-title":"CA Cancer J Clin"},{"key":"366_CR2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.2001.19.2.283","volume":"19","author":"D Kelsen","year":"2001","unstructured":"Kelsen D: Preoperative chemoradiotherapy for esophageal cancer. J Clin Oncol. 2001, 19: 283-285.","journal-title":"J Clin Oncol"},{"key":"366_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.gassur.2005.05.005","volume":"9","author":"PW Chiu","year":"2005","unstructured":"Chiu PW, Chan AC, Leung SF, Leong HT, Kwong KH, Li MK, Au-Yeung AC, Chung SC, Ng EK: Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg. 2005, 9: 794-802. 10.1016\/j.gassur.2005.05.005.","journal-title":"J Gastrointest Surg"},{"key":"366_CR4","volume-title":"Radiother Oncol","author":"JI Geh","year":"2006","unstructured":"Geh JI, Bond SJ, Bentzen SM, Glynne-Jones R: Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: Evidence of a radiation and chemotherapy dose response. Radiother Oncol. 2006"},{"key":"366_CR5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1055\/s-2005-858286","volume":"43","author":"M Hejna","year":"2005","unstructured":"Hejna M, Raderer M: [Neoadjuvant therapy for resectable esophageal cancer]. Z Gastroenterol. 2005, 43: 1141-1147. 10.1055\/s-2005-858286.","journal-title":"Z Gastroenterol"},{"key":"366_CR6","doi-asserted-by":"crossref","unstructured":"Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002, 359: 1727-1733. 10.1016\/S0140-6736(02)08651-8.","DOI":"10.1016\/S0140-6736(02)08651-8"},{"key":"366_CR7","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/jnci\/85.16.1327","volume":"85","author":"J Baselga","year":"1993","unstructured":"Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller WH, Mendelsohn J: Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst. 1993, 85: 1327-1333. 10.1093\/jnci\/85.16.1327.","journal-title":"J Natl Cancer Inst"},{"key":"366_CR8","first-page":"6461","volume":"9","author":"MK Gibson","year":"2003","unstructured":"Gibson MK, Abraham SC, Wu TT, Burtness B, Heitmiller RF, Heath E, Forastiere A: Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy. Clin Cancer Res. 2003, 9: 6461-6468.","journal-title":"Clin Cancer Res"},{"key":"366_CR9","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","volume":"37 Suppl 4","author":"RI Nicholson","year":"2001","unstructured":"Nicholson RI, Gee JM, Harper ME: EGFR and cancer prognosis. Eur J Cancer. 2001, 37 Suppl 4: S9-15. 10.1016\/S0959-8049(01)00231-3.","journal-title":"Eur J Cancer"},{"key":"366_CR10","first-page":"909","volume":"2","author":"Y Kitagawa","year":"1996","unstructured":"Kitagawa Y, Ueda M, Ando N, Ozawa S, Shimizu N, Kitajima M: Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma. Clin Cancer Res. 1996, 2: 909-914.","journal-title":"Clin Cancer Res"},{"key":"366_CR11","volume-title":"J Clin Oncol","author":"PC Enzinger","year":"2006","unstructured":"Enzinger PC, T Y, W S: Phase II cisplatin, irinotecan, cetuximab and concurrent radiation therapy followed by surgery for locally advanced esophageal cancer. J Clin Oncol. 2006, 24:"},{"key":"366_CR12","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/annonc\/mdi279","volume":"16","author":"S Segaert","year":"2005","unstructured":"Segaert S, Van CE: Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Ann Oncol. 2005, 16: 1425-1433. 10.1093\/annonc\/mdi279.","journal-title":"Ann Oncol"},{"key":"366_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1365-2168.1998.00579.x","volume":"85","author":"HE Bartels","year":"1998","unstructured":"Bartels HE, Stein HJ, Siewert JR: Tracheobronchial lesions following oesophagectomy: prevalence, predisposing factors and outcome. Br J Surg. 1998, 85: 403-406. 10.1046\/j.1365-2168.1998.00579.x.","journal-title":"Br J Surg"},{"key":"366_CR14","doi-asserted-by":"publisher","first-page":"G866","DOI":"10.1152\/ajpgi.00150.2001","volume":"282","author":"A Yanaka","year":"2002","unstructured":"Yanaka A, Suzuki H, Shibahara T, Matsui H, Nakahara A, Tanaka N: EGF promotes gastric mucosal restitution by activating Na(+)\/H(+) exchange of epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2002, 282: G866-G876.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"366_CR15","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1097\/00004836-199800001-00004","volume":"27 Suppl 1","author":"AS Tarnawski","year":"1998","unstructured":"Tarnawski AS, Jones MK: The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: involvement of EGF-R signal transduction pathways. J Clin Gastroenterol. 1998, 27 Suppl 1: S12-S20. 10.1097\/00004836-199800001-00004.","journal-title":"J Clin Gastroenterol"},{"key":"366_CR16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.ijrobp.2005.12.004","volume":"64","author":"F Lordick","year":"2006","unstructured":"Lordick F, Geinitz H, Theisen J, Sendler A, Sarbia M: Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: Report of three cases. Int J Radiat Oncol Biol Phys. 2006, 64: 1295-1298. 10.1016\/j.ijrobp.2005.12.004.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"366_CR17","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1046\/j.1365-2133.2001.04226.x","volume":"144","author":"KJ Busam","year":"2001","unstructured":"Busam KJ, Capodieci P, Motzer R, Kiehn T, Phelan D, Halpern AC: Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225. Br J Dermatol. 2001, 144: 1169-1176. 10.1046\/j.1365-2133.2001.04226.x.","journal-title":"Br J Dermatol"},{"key":"366_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/BF00165699","volume":"171","author":"RE Barrow","year":"1993","unstructured":"Barrow RE, Wang CZ, Evans MJ, Herndon DN: Growth factors accelerate epithelial repair in sheep trachea. Lung. 1993, 171: 335-344. 10.1007\/BF00165699.","journal-title":"Lung"},{"key":"366_CR19","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1165\/ajrcmb.20.4.3318","volume":"20","author":"SR White","year":"1999","unstructured":"White SR, Dorscheid DR, Rabe KF, Wojcik KR, Hamann KJ: Role of very late adhesion integrins in mediating repair of human airway epithelial cell monolayers after mechanical injury. Am J Respir Cell Mol Biol. 1999, 20: 787-796.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"366_CR20","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1096\/fj.14.10.1362","volume":"14","author":"SM Puddicombe","year":"2000","unstructured":"Puddicombe SM, Polosa R, Richter A, Krishna MT, Howarth PH, Holgate ST, Davies DE: Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J. 2000, 14: 1362-1374. 10.1096\/fj.14.10.1362.","journal-title":"FASEB J"},{"key":"366_CR21","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998, 279: 1200-1205. 10.1001\/jama.279.15.1200.","journal-title":"JAMA"},{"key":"366_CR22","first-page":"E3","volume":"2","author":"M Kvasz","year":"2000","unstructured":"Kvasz M, Allen IE, Gordon MJ, Ro EY, Estok R, Olkin I, Ross SD: Adverse drug reactions in hospitalized patients: A critique of a meta-analysis. MedGenMed. 2000, 2: E3-","journal-title":"MedGenMed"},{"key":"366_CR23","first-page":"541","volume":"21","author":"DJ Cullen","year":"1995","unstructured":"Cullen DJ, Bates DW, Small SD, Cooper JB, Nemeskal AR, Leape LL: The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv. 1995, 21: 541-548.","journal-title":"Jt Comm J Qual Improv"},{"key":"366_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30: 239-245.","journal-title":"Clin Pharmacol Ther"},{"key":"366_CR25","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1345\/aph.1G177","volume":"39","author":"SL Kane-Gill","year":"2005","unstructured":"Kane-Gill SL, Kirisci L, Pathak DS: Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit?. Ann Pharmacother. 2005, 39: 1823-1827. 10.1345\/aph.1G177.","journal-title":"Ann Pharmacother"},{"key":"366_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.gassur.2003.11.024","volume":"8","author":"ST Kelley","year":"2004","unstructured":"Kelley ST, Coppola D, Karl RC: Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy. J Gastrointest Surg. 2004, 8: 227-231. 10.1016\/j.gassur.2003.11.024.","journal-title":"J Gastrointest Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-5-114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1477-7819-5-114\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-5-114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T04:21:35Z","timestamp":1548130895000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-5-114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,11]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["366"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-5-114","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,11]]},"article-number":"114"}}